Loading clinical trials...
Loading clinical trials...
A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Polidocanol Injectable Foam 0.5%, 1.0%, or 2.0% Compared to Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
Conditions
Interventions
Polidocanol injectable foam (PEM)
Placebo Vehicle
Locations
20
United States
Laguna Hills, California, United States
San Diego, California, United States
Washington D.C., District of Columbia, United States
Aventura, Florida, United States
Bradenton, Florida, United States
Oakbrook Terrace, Illinois, United States
Start Date
December 1, 2010
Primary Completion Date
December 1, 2011
Completion Date
November 1, 2012
Last Updated
April 21, 2021
NCT07449728
NCT05735639
NCT06711120
NCT06693245
NCT03416413
NCT04487314
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions